During the past decade, Paratus Clinical Research Brisbane conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paratus Clinical Research Brisbane" #1 sponsor was "Novavax" with 2 trials, followed by "Actinogen Medical" with 1 trials sponsored, "BioNTech SE" with 1 trials sponsored, "Cerecin" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paratus Clinical Research Brisbane" #1 collaborator was "Avance Clinical" with 1 trials as a collaborator, "BioNet-Asia" with 1 trials as a collaborator, "Chulalongkorn University" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Paratus Clinical Research Brisbane" are "COVID-19" (3 trials), "Alzheimer's Disease" (1 trials), "COVID-19, SARS CoV 2 Infection" (1 trials), "Colitis, Ulcerative" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Paratus Clinical Research Brisbane" in a lesser frequency.

Most popular intervention types in "Paratus Clinical Research Brisbane" are "Drug" (6 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Seasonal Inactivated Influenza Vaccine" (2 trials), "BNT162b2" (1 trials), "CIC Vaccine" (1 trials) and "ChulaCov19 BNA159 vaccine (50 mcg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Paratus Clinical Research Brisbane" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Paratus Clinical Research Brisbane". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Paratus Clinical Research Brisbane, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Paratus Clinical Research Brisbane, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".